2/25/2026CDE Solicits Comments on Batch 104 of Chemical Generic Reference Formu...

2/25/2026Kelun-Biotech's sac-TMT OS Data Selected as Late-Breaker at ELCC 2026

2/25/2026Prodegre Closes Angel+ Round to Advance CNS Pipeline and ATLAS™ Platf...

2/25/2026Slate Medicines Launches With $130M to Advance China-Licensed PACAP Mi...

2/25/2026Henlius Expands Global Footprint with Exclusive Abbott Licensing Deal ...

2/24/2026Biokin's Iza-Bren Achieves Second Phase III Survival Success in China ...

2/24/2026China Prepares to Implement Landmark Regulations for Clinical Research...

2/24/2026CDE Issues Guidelines on Benefit-Risk Assessment Using Multi-Regional ...

2/24/2026CDE Releases Q&A Document on Development Safety Update Reports

2/24/2026CDE Issues Guideline on Clinical Information for CAR-T Therapy Package...

2/24/2026Huadong Launches Head-to-Head Phase III Trial for Dual GLP-1/GIP Agoni...

2/24/2026GenSci Advances PD-1 Agonist Into Phase 2b for Rheumatoid Arthritis

2/24/2026Ascentage Registers U.S. Phase 1 Trial for BTK PROTAC APG-3288

2/24/2026Harbour BioMed Strikes $1.1B-Plus Ex-China Deal for Anti-CTLA-4 Antibo...

2/24/2026Frontier Biotech Inks Global siRNA Licensing Deal with GSK

2/24/2026XtalPi and YolTech Forge AI Alliance to Advance mRNA and In Vivo CAR-T...

2/24/2026United Labs and Novo Nordisk Post Strong Phase 2 Data for UBT251 Tripl...

2/24/2026Pfizer Acquires China Rights to Sciwind's Approved GLP-1 Therapy

2/21/2026Leo Pharma Eyes China Comeback After Decade-Long Launch Drought

2/21/2026Hansoh Pharma's Ameile Wins EU Approval for EGFR-Mutant Lung Cancer

2/20/2026CSPC's Long-Acting SYH2082 Clears FDA to Begin Clinical Trials

2/16/2026CSPC's Long-Acting Ropivacaine Injection Cleared for Clinical Trials i...

2/16/2026FindCure Secures CNY 100M+ Series B to Accelerate Cancer Therapy Progr...

2/16/2026CStone's Trispecific Antibody CS2009 Receives FDA IND Clearance, Ente...

2/14/2026Recordati to Withdraw from China After Rare Disease Portfolio Underper...

2/13/2026Shenzhen Immunofoco Biotechnology files Hong Kong IPO application

2/13/2026ProteLight Pharmaceuticals Files Hong Kong IPO application

2/13/2026VivaVision Files Hong Kong IPO to Fund Late-Stage Ophthalmology Progra...

2/13/2026Salubris Files Hong Kong IPO to Expand Cardiovascular-Kidney-Metabolic...

2/13/2026Pentagon Reverses Decision After Briefly Listing WuXi AppTec as Chines...

Page:10/62 Total number of articles:1841: [First][<<] [8] [9] [10] [11] [12] [>>] [End]